Richard T. Davey - Concepedia

Author

Richard T. Davey

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

Craig Coopersmith, Davey, Davey, R, David Cohen, Hoepelman, A.I.M., J Beigel, Janaki Amin, John Beigel, Konstantinos Protopapas, R Davey

237

Publications

20.1K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health National Institutes of Health Clinical Center Science Applications International Corporation (United States)National Cancer Institute

About

Richard T. Davey is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	51	4.5K
2	Allergy	5	5	570
3	Public Health	4	4	113
4	Natural Sciences	1	1	162
5	Biochemistry	1	1	33

Richard T. Davey

156

Publications

18.8K

Citations

H-Index

Page 1

	Year	Citations
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, New England Journal of Medicine	2020	1.9K
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics Sabué Mulangu, Lori E. Dodd, Richard T. Davey, New England Journal of Medicine	2019	1.6K
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Richard T. Davey, Niranjan Bhat, Christian Yoder, Proceedings of the National Academy of Sciences	1999	849
Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis Sarah Palmer, Mary F. Kearney, Frank Maldarelli, Journal of Clinical Microbiology	2005	503
Re-emergence of HIV after stopping therapy Tae‐Wook Chun, Richard T. Davey, Delphine Engel, Nature Treatment And PreventionHuman RetrovirusVirologyChronic Viral InfectionHiv	1999	432
Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study Joseph A. Kovacs, Michael Baseler, Robin Dewar, New England Journal of Medicine	1995	427
Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert, New England Journal of Medicine	1996	408
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy Tae‐Wook Chun, Delphine Engel, Stephanie B. Mizell, Nature Medicine Primary ImmunodeficiencyAutoimmune DiseaseActive Anti-retroviral TherapyHuman RetrovirusImmunology	1999	407
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy Tae-Wook Chun, Richard T. Davey, Mario Ostrowski, Nature Medicine Plasma ViremiaViral PersistenceActive Anti-retroviral TherapyImmunologyAntiviral Response	2000	406
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019 Peter D. Burbelo, Francis X. Riedo, Chihiro Morishima, The Journal of Infectious Diseases	2020	402

Page 1